Pelvic exenteration as palliation of malignant disease
- PMID: 57724
- DOI: 10.1016/0002-9610(76)90166-5
Pelvic exenteration as palliation of malignant disease
Abstract
It has been traditional to exclude patients with radiation-recurrent carcinoma of the uterine cervix or other pelvic neoplasms, incapacitating pelvic pain, postirradiation fistulas, hemorrhage, or malodorous draining tumor necrosis from pelvic exenteration if cure of the malignant disease is not achievable. This negative attitude is a direct result of the reported high morbidity, prohibitive mortality, and low salvage rate previously associated with pelvic exenteration, the only acceptable surgical approach to these diseases. A recent experience with eighteen patients who underwent pelvic exenteration for advanced primary or recurrent carcinoma of the cervix, urinary bladder, or rectum has led us to challenge several traditional concepts regarding this operative procedure. We have observed but one operative death and our morbidity has been minimal. This may reflect our belief that an aggressive pelvic lymphadenectomy in those patients with direct visceral involvement from radiation-recurrent carcinoma of the pelvic viscera is not advantageous since no significant survival has ever been documented for patients with pathologic visceral involvement and positive lymph nodes. In addition, significant morbidity has always been associated directly with pelvic lymphadenectomy in the irradiated pelvis, and elimination of this phase of the operation in selected patients with radiation-recurrent carcinoma is indicated. Moreover, the considerable decrease in morbidity and the minimal mortality observed have led us to adopt a very liberal attitude toward preoperative selection criteria, and we regularly now use pelvic exenteration not only for cure but as intentional palliation in selected patients. We strongly believe that elimination of pain, fistulas, pelvic sepsis, hemorrhage, and malodorous areas of tumor necrosis are important for improving the quality of life for both the patient and family.
Similar articles
-
New look at pelvic exenteration.Urology. 1976 Apr;7(4):355-61. doi: 10.1016/0090-4295(76)90245-4. Urology. 1976. PMID: 57661
-
Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.J Urol. 2003 Nov;170(5):1868-71. doi: 10.1097/01.ju.0000091656.94825.90. J Urol. 2003. PMID: 14532795
-
The role of surgery in the palliation of advanced pelvic malignancy.Eur J Surg Oncol. 2022 Nov;48(11):2323-2329. doi: 10.1016/j.ejso.2022.01.019. Epub 2022 Jan 21. Eur J Surg Oncol. 2022. PMID: 35123817
-
Pelvic exenteration for recurrent colorectal carcinoma: a review.Cancer Invest. 1994;12(2):176-88. doi: 10.3109/07357909409024873. Cancer Invest. 1994. PMID: 8131093 Review.
-
Palliative pelvic exenteration: patient selection and results.Oncology (Williston Park). 1996 Apr;10(4):479-84; discussion 484-6, 490, 493. Oncology (Williston Park). 1996. PMID: 8723278 Review.
Cited by
-
Pelvic exenteration for locally advanced colorectal carcinoma.Ann Surg. 1982 Apr;195(4):513-8. doi: 10.1097/00000658-198204000-00022. Ann Surg. 1982. PMID: 6175286 Free PMC article.
-
Total pelvic exenteration in colorectal disease: A 20-year experience.Ann Surg. 1981 Dec;194(6):701-3. doi: 10.1097/00000658-198112000-00007. Ann Surg. 1981. PMID: 7305482 Free PMC article. No abstract available.
-
The role of palliative surgery in gynecologic cancer cases.Oncologist. 2013;18(1):73-9. doi: 10.1634/theoncologist.2012-0328. Epub 2013 Jan 8. Oncologist. 2013. PMID: 23299775 Free PMC article. Review.
-
Redo Pelvic Surgery and Combined Metastectomy for Locally Recurrent Rectal Cancer with Known Oligometastatic Disease: A Multicentre Review.Cancers (Basel). 2023 Sep 8;15(18):4469. doi: 10.3390/cancers15184469. Cancers (Basel). 2023. PMID: 37760439 Free PMC article.
-
Palliative pelvic exenteration using iliofemoral bypass with synthetic grafts for advanced cervical carcinoma.Turk J Obstet Gynecol. 2019 Mar;16(1):80-83. doi: 10.4274/tjod.galenos.2018.66743. Epub 2019 Mar 27. Turk J Obstet Gynecol. 2019. PMID: 31019845 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources